American Herbal Products Association (AHPA) > News > AHPA Updates

AHPA Updates

Updates on AHPA activities and resources delivered to your inbox. Subscribe today!

Pullulan added to NOSB National List

July 2021: Substance allowed in “made with organic” supplement tablets or capsules

In a final rule notice published June 25, U.S. Department of Agriculture’s (USDA’s) Agricultural Marketing Service announced the addition of pullulan to the National List of Allowed and Prohibited Substances (the National List).

IADSA update on international supplement regulations

IADSA update on international supplement regulations

June 2021 IADSA Newsflash

In this issue of the IADSA Newsflash:Korea is amending its functional food code to include precautions for certain products; Korea has updated its functional food code to recognize additional mineral sources and limits for EPA DHA.; The European Food Safety Authority (EFSA) is assessing the potential risk of vitamin D overdose; Alpha lipoic acid is under review by EFSA, who concluded that it may represent a risk to individuals with insulin autoimmune syndrome, but were unable to quantify the risk.; and more!

USDA APHIS to delay Lacey Act Phase VI enforcement

June 2021: Import declarations for “other” essential oils indefinitely deferred

Dorothy Wayson, National Policy Manager for the Lacey Act at the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), made two significant announcements at an AHPA webinar Wednesday regarding changes to the upcoming Phase VI of Lacey Act’s import declaration enforcement implementation.

AHPA Guidance: Federal Labeling Requirements for Herbal Dietary Supplements

June 2021: Free guidance for AHPA members, log-in to download

AHPA has revised its labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for dietary supplements, and is making the updated guidance document available FREE to members.

June 2021 AHPA Report

AHPA Members, Log in to access the AHPA Report

The June 2021 AHPA Report includes: AHPA has released updates to the Botanical Safety Handbook; AHPA updates GACP-GMP guidance; AHPA updates Primer on CITES; and more!

AHPA letter to new US Trade Representative requests tariff relief

June 2021 - Letter also cites the organization’s extensive previous comments to the USTR on this matter

The American Herbal Products Association (AHPA) delivered a letter to US Trade Representative Katherine Tai this month requesting the removal of punitive tariffs from a range of products relevant to the herbal products industry.

AHPA updates GACP-GMP guidance to include new appendix on prevention of pyrrolizidine alkaloid contamination

Update replaces the 2017 version of the document

The American Herbal Products Association (AHPA) has updated its guidance document “Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Materials” (AHPA GACP-GMP) to include a new appendix addressing prevention of pyrrolizidine alkaloid contamination.

AHPA releases 2021 update to free Primer on Convention on International Trade in Endangered Species (CITES)

May 2021 Revision

AHPA has updated its “Primer on Importing and Exporting CITES-Listed Species,” a free resource that provides the herbal industry with the latest information on the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).

California bill restricting minor access to supplements deferred to 2022

May 21, 2021 - Bill held by Appropriations Committee until assembly reconvenes in January

A recent California Assembly Bill 1341 (AB 1341) that would place heavy restrictions on a broad range of dietary supplements has been held up in the state Appropriations Committee, seriously delaying its passage.

Bipartisan Legislation Introduced in U.S. Senate Would Create Regulatory Pathways for Use of Hemp-Derived CBD in Dietary Supplements and Conventional Food

May 2021 - Bill would remove restrictions for use in foods and dietary supplements

Silver Spring, MD, May 19, 2021 – Today, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace.

RSS
12345678910 Last